Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

‘Unbalanced’ EU HTA Timelines Exacerbated By Rare Disease & Cancer Drugs

deadline

Related Content

EU HTA Regulation: Companies Want Bigger Role In Shaping Assessments

Aug 02 2023

EU Opens Long Awaited Consultation On Joint Clinical Assessments

Mar 08 2024

Proposed EU HTA Methods Pose Challenges For Cancer Therapies, Warns EFPIA

Apr 02 2024

Pharma Dubs EU HTA Proposal ‘Unworkable,’ But Patient Groups Support The Plan

Apr 04 2024

Additional Topics

Europe EU Health Technology Assessment Market Access Regulation Policy BioPharmaceutical

More from Health Technology Assessment

More from Market Access

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window